Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs directed at increasing the horizons of cytokine-based immunotherapy, especially for cancers where procedure selections remain limited. Utilize the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/21x-taps-philip-filhol-for-business-development-ahead-of-exchange-launch/